AstraZeneca

This week saw a round of updates from some of the UK's largest dividend payers, including BP, Shell, Glaxo and British American Tobacco. But is it time for investors to be selling the big names?

Jayesh Manek's £40m Manek Growth fund has soared to the top of the UK All Companies sector, losing just 2.5% in the last three months of excessive market volatility.

The Trojan Income fund's Francis Brooke says UK investors should shun volatility for the best returns.